CLINICAL_TRIALS
trial_result
· 2022-06-29
Clinical Trial Update: Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma [Phase 2]
Summary
Phase 2 trial evaluating avelumab with hypofractionated radiation therapy in IDH-mutant glioblastoma completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2022-06-29